Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jun;62(6):648-649.
doi: 10.1111/head.14330. Epub 2022 Jun 7.

Twenty twenty … two: Headache and COVID-19

Edoardo Caronna  1   2 , Patricia Pozo-Rosich  1   2
Affiliations
Editorial

Twenty twenty … two: Headache and COVID-19

Edoardo Caronna et al. Headache. 2022 Jun.
No abstract available

Keywords: COVID-19; epidemiology; headache.

PubMed Disclaimer

Conflict of interest statement

Dr. Caronna has received honoraria from Novartis and Chiesi. Dr. Pozo‐Rosich has received honoraria as a consultant and speaker for: Allergan‐AbbVie, Almirall, Biohaven, Chiesi, Eli Lilly, Medscape, Neurodiem, Novartis, and Teva. Her research group has received research grants from Novartis; has received funding for clinical trials from Alder, Amgen, Electrocore, Eli Lilly, Novartis, and Teva. She is a trustee member of the board of the International Headache Society and the Council of the European Headache Federation. She is on the editorial board of Revista de Neurologia. She is an editor for Cephalalgia, Headache, Neurologia, Frontiers of Neurology, and advisor for The Journal of Headache and Pain. She is a member of the Clinical Trials Guidelines Committee of the International Headache Society. She has edited the Guidelines for the Diagnosis and Treatment of Headache of the Spanish Neurological Society. She is the founder of www.midolordecabeza.org. She does not own stocks from any pharmaceutical company.

Similar articles

See all similar articles

Cited by

References

    1. Caronna E, Ballvé A, Llauradó A, et al. Headache: a striking prodromal and persistent symptom, predictive of COVID‐19 clinical evolution. Cephalalgia. 2020;40:1410‐1421. - PMC - PubMed
    1. Membrilla JA, de Lorenzo Í, Sastre M, Díaz de Terán J. Headache as a cardinal symptom of coronavirus disease 2019: a cross‐sectional study. Headache. 2020;60:2176‐2191. - PMC - PubMed
    1. Porta‐Etessam J, Matías‐Guiu JA, González‐García N, et al. Spectrum of headaches associated with SARS‐CoV‐2 infection: study of healthcare professionals. Headache. 2020;60(8):1697‐1704. - PMC - PubMed
    1. Poncet‐Megemont L, Paris P, Tronchere A, et al. High prevalence of headaches during Covid‐19 infection: a retrospective cohort study. Headache. 2020;60:2578‐2582. - PMC - PubMed
    1. Rocha‐Filho PAS, Magalhães JE. Headache associated with COVID‐19: frequency, characteristics and association with anosmia and ageusia. Cephalalgia. 2020;40(13):1443‐1451. - PMC - PubMed

Publication types